<DOC>
	<DOC>NCT00725179</DOC>
	<brief_summary>Retrospective chart review of patients who received N-acetylcysteine for APAP toxicity to assess length of oral vs IV treatment and overall healthcare costs.</brief_summary>
	<brief_title>Treatment of Acetaminophen Toxicity With N-acetylcysteine</brief_title>
	<detailed_description />
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Admitted to CHMCA between June 1, 2004 to May 31, 2008 with a qualifying ICD9 diagnosis code for the following APAP overdose situations; poisoning, accidental, suicide attempt, therapeutic use, assault, and undetermined (965.4, E850.4, E950.0, E935.4, E962.0, E980.0) Serum APAP concentrations â‰¥ 150 g/mL at 4 hours or a serum concentration above the possible hepatotoxic line on the RumackMatthew's nomogram if obtained &gt; 4 hours post ingestion Between the ages of 021 years Serum APAP concentrations are not actually documented Patient did not receive oral or IV NAC treatment Patient has a preexisting liver disease such as cirrhosis or hepatitis C Patient &gt; 21 years of age</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>acetaminophen toxicity</keyword>
	<keyword>n-acetylcysteine</keyword>
	<keyword>liver toxicity</keyword>
</DOC>